Common Contracts
2 similar License Agreement contracts by Khosla Ventures Acquisition Co.
LICENSE AGREEMENT between SANOFI and VALO HEALTH, INC. Dated as of May 10, 2021License Agreement • October 20th, 2021 • Khosla Ventures Acquisition Co. • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”) is made and entered into as of May 10, 2021 (the “Effective Date”) by and between Sanofi, a French corporation, having offices at 54, rue la Boétie, 75008 Paris (“Sanofi” or “Licensor”), and, Valo Health, Inc., a Delaware corporation, with a principal office at 399 Boylston Street, Suite 505, Boston, MA 02116 (“Valo” or “Licensee”). Sanofi and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
LICENSE AGREEMENT between SANOFI and VALO HEALTH, INC. Dated as of February 8, 2021License Agreement • October 20th, 2021 • Khosla Ventures Acquisition Co. • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”) is made and entered into as of February 8, 2021 (the “Effective Date”) by and between Sanofi, a French corporation, having offices at 54, rue la Boétie, 75008 Paris (“Sanofi” or “Licensor”), and, Valo Health, Inc., a Delaware corporation, with a principal office at 399 Boylston Street, Suite 505, Boston, MA 02116 (“Valo” or “Licensee”). Sanofi and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
